SAFC Pharma, part of the Sigma-Aldrich Group, has completed an addition to its Carlsbad, CA, facility, expanding its contract manufacturing services for its late phase and commercial clients. The $12 million project includes the addition of two fully segregated state-of-the-art viral product manufacturing suites, built to employ disposable bioreactor technologies, expanding SAFC Pharma’s biologics, viral vaccines and gene therapy manufacturing to commercial-scale quantities. The Carlsba...